Opus Genetics
IRD
35 hedge funds and large institutions have $5.94M invested in Opus Genetics in 2015 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 9 increasing their positions, 10 reducing their positions, and 5 closing their positions.
5% more capital invested
Capital invested by funds: $5.65M → $5.94M (+$292K)
8% less funds holding
Funds holding: 38 → 35 (-3)
10% less repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 10
60% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$235K |
| 2 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$215K |
| 3 |
Renaissance Technologies
New York
|
+$102K |
| 4 |
Wells Fargo
San Francisco,
California
|
+$93K |
| 5 |
CCM
Condor Capital Management
Martinsville,
New Jersey
|
+$67.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VKH
Virtu KCG Holdings
New York
|
-$252K |
| 2 |
Morgan Stanley
New York
|
-$176K |
| 3 |
AQR Capital Management
Greenwich,
Connecticut
|
-$55.2K |
| 4 |
Goldman Sachs
New York
|
-$47.2K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$29.8K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Canada Life
Winnipeg,
Manitoba, Canada
| $6K | – | – | – |
|
27
Citigroup
New York
| $5K | – | – | – |
|
|
28
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| $3K | -$29.8K | -82 | -89% |
|
|
WA
29
WFG Advisors
Dallas,
Texas
| $3K | -$2.9K | -8 | -53% |
|
|
TWA
30
TCI Wealth Advisors
Tucson,
Arizona
| $2K | +$2.18K | +6 | New |
|
|
CP
31
Corbenic Partners
Bethlehem,
Pennsylvania
| $1K | – | – | – |
|
32
Royal Bank of Canada
Toronto,
Ontario, Canada
| $1K | +$363 | +1 | +50% |
|
|
33
Morgan Stanley
New York
| – | -$176K | -525 | Closed |
|
34
Commonwealth Equity Services
Waltham,
Massachusetts
| – | -$16K | -49 | Closed |
|
35
Citadel Advisors
Miami,
Florida
| – | -$10K | -31 | Closed |
|
|
FA
36
FCG Advisors
Chatham,
New Jersey
| – | -$11K | -31 | Closed |
|
|
NPC
37
National Planning Corporation
El Segundo,
California
| – | -$1.6K | -4 | Closed |
|
|
TRCT
38
Tower Research Capital (TRC)
New York
| – | -$726 | -2 | -67% |
|
39
PNC Financial Services Group
Pittsburgh,
Pennsylvania
| – | +$363 | +1 | New |
|
IRD Hedge Fund Activity: Q1 2015 in Review
35 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Opus Genetics (IRD) for Q1 2015, worth a combined $5.94M — up 5.2% from $5.65M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of IRD and 2 opened new positions — a net loss of 3 holders — while 10 trimmed existing stakes and 9 added.
The largest buyer was Vanguard Group, adding an estimated $235K. The largest seller was Virtu KCG Holdings, cutting an estimated $252K.
- 35 institutional investors held Opus Genetics (IRD) as of Q1 2015, down from 38 in Q4 2014.
- Funds reported $5.94M of Opus Genetics stock for Q1 2015, up 5.2% quarter-over-quarter.
- 2 funds opened new Opus Genetics positions in Q1 2015 and 5 closed out, a net change of -3 holders.
- The largest Opus Genetics buyer in Q1 2015 was Vanguard Group, an estimated $235K added.
- The largest Opus Genetics seller in Q1 2015 was Virtu KCG Holdings, an estimated $252K sold.
Based on aggregated 13F filings for Q1 2015.